Biostate AI closes $12M to bring the Netflix model to molecular diagnostics
Posted:
Biostate AI, a leading innovator in artificial intelligence and RNA sequencing, announced the successful completion of a $12M Series A funding round, led by Accel. The company’s immediate focus is revolutionizing RNAseq accessibility and developing clinically relevant predictive models.
The Swedish company Everdrone is launching a newly developed drone (E3) designed to enable both more frequent and faster deployments to emergency calls. The drone can also be equipped to carry both defibrillators and other emergency medical equipment.
Read more…
In the demanding environment of the NHS, asking staff to find extra time for exercise can feel like 1 more burden on an already stretched workforce – much like telling someone who’s burned out to simply be more resilient. Yet…